Brief: Nabriva Agrees To Extension Of Principal Debt Repayments Under Existing Loan Agreement With Hercules Capital
03/06/2021 12:57
June 3 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA AGREES TO EXTENSION OF PRINCIPAL DEBT REPAYMENTS
UNDER
EXISTING LOAN AGREEMENT WITH HERCULES CAPITAL
* NABRIVA THERAPEUTICS PLC - PRINCIPAL REPAYMENTS DELAYED AT
LEAST
UNTIL JANUARY 1, 2022
* NABRIVA THERAPEUTICS PLC - REPAYMENT DELAY AND RECENT ATM
ACTIVITY EXTENDS CASH RUNWAY SUBSTANTIALLY THROUGH Q1 OF 2022
Source text for Eikon: ID:nGNXDywKc
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update